Home
Technology Platform
Main Business
News
About Us
Contact Us
Company Introduction

We are committed to becoming a leader of Marketing Authorization solutions for the medical industry and continues to create new value for health.

Suzhou Soho Biomaterials Technology Co., Ltd (Healtech Suzhou CDMO Center) was founded in January 2006 and is located in Soho Industrial Park, No.105 Tianshangjiang Road, Wuzhong Economic Development Zone, Suzhou, Jiangsu, China. After the acquisition of Suzhou Soho Biomaterials Technology Co., Ltd. by Healtech Group, Suzhou CDMO Center was set up. After integration, the Center has the functions of R&D, clinical trials, product registration, and large-scale production.Empowering pharmaceutical and medical device companies, this platform is a one-stop CDMO service supplier for the transformation of high-quality medical device scientific and technological achievements, providing a package of Marketing Authorization solutions.

The company has built more than 3,000 square meters of GMP clean workshop and R&D laboratory, equipped with Class 10,000 workshop purification areas, and established biological, chemical and physical testing room, including aseptic testing room, positive control room and microbial limit check room. The company has a team of the leading experts in the field of silk fibroin, the chief scientists of the 13th Five-Year Plan, scientists from Soochow University as the technical consultants,and gathered experts and professionals in biomaterials, medicine and pharmacy. We establishes a perfect quality management system for R&D and manufacturing to accomplish the breakthrough of a number of original innovation achievements from 0 to 1. The successful development of Soho artificial skin marks China have independent intellectual property rights of the tissue engineering scaffold materials - porous silk pigment, in the field of artificial skin research and application of China's skin to fill the gaps in the field of high-tech skin tissue engineering.

The company had undertaken the special project of "National 13th Five Year Key R&D Plan for Biomaterials Research and Development and Organ Repair Replacement", realizing the transformation of scientific and technological achievements in "Engineering preparation technology and product development of low immunogenicity collagen and silk fibroin protein", At the same time, we have participated in the transformation of the scientific research results of a number of National High Technology Research and Development Program (National 863 Program) projects, including "research on soft tissue repair materials of silk fibroin", "research on the application of silk fibroin as a biomedical material and product development", etc.We also have further reserved various research and development technologies of new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, pectin, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc.

At present, we have applied for more than 20 national invention patents, obtained 5 national invention patent certificates, 2 medical device registration certificates, reserved more than 50 technical projects, completed three medical device raw material master file registrations, and won the "National High-tech Enterprise Certification" and other honors.


Web:www.suhaobio.com.cn

Add:Soho Industrial Park, No.105 Tianshangjiang Road, Wuzhong 

Economic Development Zone, Suzhou, Jiangsu, P.R.China

Hotline:(+86)400-080-9519

  Email:services@healtech.com.cn


Share:

Copyright ©2020 www.suhaobio.com.cn, All Rights Reserved
Jiangsu lCP No. 19075400-1  Jiangsu Computer Information Network and internet  unit registration No. 32050602011157 Qualification Certificate for Medicine Trading Services on the Internet:(Jiangsu)-Non-Operating-2020-0041